Open access · CC-BY
via OpenAlex
Tetrahydroxy stilbene glucoside rejuvenates aging hematopoietic stem cells with predilection for lymphoid differentiation via AMPK and Tet2
Dan Gao, Weiwei Yi, Bo Liu, Cong-En Zhang, Cui-cui Yang, Li Zeng, Lin Li, Guangbin Luo, Lan Zhang, Zhenyu Ju, Jiabo Wang
Journal of Advanced Research · 2024 · ▲ 15 citations
Epigenetic alterations
Deregulated nutrient-sensing
Cellular senescence
Stem-cell exhaustion
Human
Mouse
Abstract
INTRODUCTION: Aging of hematopoietic stem cells (HSCs) has emerged as an important challenge to human health. Recent advances have raised the prospect of rejuvenating aging HSCs via specific medical interventions, including pharmacological treatments. Nonetheless, efforts to develop such drugs are still in infancy until now. OBJECTIVES: We aimed to screen the prospective agents that can rejuvenate aging HSCs and explore the potential mechanisms. METHODS: We screened a set of natural anti-aging compounds through oral administration to sub-lethally irradiated mice, and identified 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside (TSG) as a potent rejuvenating agent for aging HSCs. Then naturally aged mice were used for the follow-up assessment to determine the HSC rejuvenating potential of TSG. Finally, based on the transcriptome and DNA methylation analysis, we validated the role of the AMP-activated protein kinase (AMPK)-ten-eleven-translocation 2 (Tet2) axis (the AMPK-Tet2 axis) as the underlying mechanisms of TSG for ameliorating HSCs aging. RESULTS: TSG treatment not only significantly increased the absolute number of common lymphoid progenitors (CLPs) along with B lymphocytes, but also boosted the HSCs/CLPs repopulation potential of aging mice. Further elaborated mechanism research demonstrated that TSG supplementation restored the stemness of aging HSCs, as well as promoted an epigenetic reprograming that was associated with an improved regenerative capacity and an increased rate of lymphopoiesis. Such effects were diminished when the mice were co-treated with an AMPK inhibitor, or when it was performed in Tet2 knockout mice as well as senescent cells assay. CONCLUSION: TSG is effective in rejuvenating aging HSCs by modulating the AMPK- Tet2 axis and thus represents a potential candidate for developing effective HSC rejuvenating therapies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.jare.2024.04.027
- Canonical
- link ↗
- Fetched
- 2026-10-24 MST
Cite this
APA
Gao, D., Yi, W., Liu, B., Zhang, C., Yang, C., Zeng, L., Li, L., Luo, G., Zhang, L., Ju, Z., & Wang, J. (2024). Tetrahydroxy stilbene glucoside rejuvenates aging hematopoietic stem cells with predilection for lymphoid differentiation via AMPK and Tet2. <em>Journal of Advanced Research</em>. https://doi.org/10.1016/j.jare.2024.04.027
Vancouver
Gao D, Yi W, Liu B, Zhang C, Yang C, Zeng L, et al. Tetrahydroxy stilbene glucoside rejuvenates aging hematopoietic stem cells with predilection for lymphoid differentiation via AMPK and Tet2. Journal of Advanced Research. 2024. doi:10.1016/j.jare.2024.04.027.
BibTeX
@article{dan2024Tetrah,
title = {Tetrahydroxy stilbene glucoside rejuvenates aging hematopoietic stem cells with predilection for lymphoid differentiation via AMPK and Tet2},
author = {Dan Gao and Weiwei Yi and Bo Liu and Cong-En Zhang and Cui-cui Yang and Li Zeng and Lin Li and Guangbin Luo and Lan Zhang and Zhenyu Ju and Jiabo Wang},
journal = {Journal of Advanced Research},
year = {2024},
doi = {10.1016/j.jare.2024.04.027},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
bioRxiv (Cold Spring Harbor Laboratory) 2024
Preprint · OA
Platelet Factor 4 (PF4) Regulates Hematopoietic Stem Cell Aging
Blood 2025
Citation only
Platelet factor 4 regulates hematopoietic stem cell aging
Blood 2025
Citation only
Platelet factor 4 regulates hematopoietic stem cell aging.
Advanced Science 2025
Open access · CC-BY
A Novel Therapeutic Strategy for Bone Marrow Failure: Niche Rejuvenation Using Costal Cartilage‐Derived Stem Cells
Mechanobiology in Medicine 2023
Open access · CC-BY
Stiffness matters: A soft bone marrow organoid rejuvenates hematopoietic stem cells
FEBS Letters 2024
Open access · CC-BY